INVO Fertility (IVF) Common Equity (2010 - 2026)

INVO Fertility (IVF) has 17 years of Common Equity data on file, last reported at $15.0 million in Q1 2026.

• On a quarterly basis, Common Equity rose 373.58% year-over-year to $15.0 million in Q1 2026; TTM through Mar 2026 was $15.0 million, a 373.58% increase from a year earlier, with the FY2025 full-year figure at $7.2 million, down 42.59% from the prior year.
• Common Equity for Q1 2026 stood at $15.0 million, up from $7.2 million in the prior quarter.
• Over the last five years, Common Equity for IVF reached as high as $15.0 million in Q1 2026 and fell as low as -$1.7 million in Q2 2023.
• Historically, Common Equity has averaged $3.3 million across 5 years, with a median of $1.4 million in 2024.
• Across the five-year window, Common Equity plunged 150.81% in 2023 and jumped 31139.16% in 2025, its largest moves.
• Year by year, Common Equity stood at -$977612.0 in 2022, then surged by 191.33% to $892825.0 in 2023, then surged by 1309.5% to $12.6 million in 2024, then tumbled by 42.59% to $7.2 million in 2025, then surged by 107.96% to $15.0 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $15.0 million in Q1 2026, $7.2 million in Q4 2025, and $5.8 million in Q3 2025.